$21.93
0.0%
Downside
Day's Volatility :5.35%
Upside
5.35%
16.55%
Downside
52 Weeks Volatility :31.25%
Upside
17.62%
Period | Bioage Labs Inc. | Index (Russel 2000) |
---|---|---|
3 Months | 19.77% | 0.0% |
6 Months | 19.77% | 0.0% |
1 Year | 19.77% | 0.0% |
3 Years | 19.77% | -27.4% |
Market Capitalization | 674.1M |
Book Value | -$114.37 |
Earnings Per Share (EPS) | -5.4 |
Profit Margin | 0.0% |
Operating Margin TTM | 0.0% |
Return On Assets TTM | 0.0% |
Return On Equity TTM | 0.0% |
Revenue TTM | 0.0 |
Revenue Per Share TTM | 0.0 |
Quarterly Revenue Growth YOY | 0.0% |
Gross Profit TTM | 0.0 |
EBITDA | -51.4M |
Diluted Eps TTM | -5.4 |
Quarterly Earnings Growth YOY | 0.0 |
EPS Estimate Current Year | 0.0 |
EPS Estimate Next Year | 0.0 |
EPS Estimate Current Quarter | 0.0 |
EPS Estimate Next Quarter | 0.0 |
Sell
Neutral
Buy
Bioage Labs Inc. is currently not in a favorable trading position ( SELL ) according to technical analysis indicators.
Company Name | 1 Month | 6 Month | 1 Year | 3 Years | 5 Years |
---|---|---|---|---|---|
Bioage Labs Inc. | -1.22% | 19.77% | 19.77% | 19.77% | 19.77% |
Neurocrine Biosciences Inc. | 8.35% | -14.24% | 6.6% | 29.88% | 18.5% |
Haleon Plc Spon Ads | -2.59% | 18.57% | 20.47% | 31.85% | 31.85% |
Zoetis Inc. | -6.41% | 5.62% | 7.42% | -19.53% | 44.29% |
Viatris Inc. | 2.47% | -1.78% | 26.06% | -20.91% | -28.95% |
Catalent, Inc. | -3.51% | 3.74% | 70.6% | -52.84% | 19.06% |
Company Name | P/E Ratio | P/B Ratio | PEG Ratio | EPS | ROE | ROA | Div Yield | BVPS |
---|---|---|---|---|---|---|---|---|
Bioage Labs Inc. | NA | NA | NA | 0.0 | 0.0 | 0.0 | NA | -114.37 |
Neurocrine Biosciences Inc. | 32.58 | 32.58 | 0.28 | 4.16 | 0.16 | 0.12 | NA | 26.87 |
Haleon Plc Spon Ads | 28.71 | 28.71 | 1.44 | 0.38 | 0.07 | 0.04 | 0.02 | 1.82 |
Zoetis Inc. | 35.68 | 35.68 | 2.58 | 5.82 | 0.49 | 0.14 | 0.01 | 10.9 |
Viatris Inc. | 224.4 | NA | 0.07 | 2.67 | -0.03 | 0.03 | 0.04 | 16.36 |
Catalent, Inc. | 211.02 | NA | 2.94 | 0.2 | -0.25 | 0.0 | NA | 19.91 |
Company Name | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin |
---|---|---|---|---|---|
Bioage Labs Inc. | NA | NA | 19.77% | NA | 0.0% |
Neurocrine Biosciences Inc. | Buy | $12.4B | 18.5% | 32.58 | 17.21% |
Haleon Plc Spon Ads | Buy | $44.1B | 31.85% | 28.71 | 10.75% |
Zoetis Inc. | Buy | $82.4B | 44.29% | 35.68 | 26.29% |
Viatris Inc. | Hold | $13.7B | -28.95% | 224.4 | -4.24% |
Catalent, Inc. | Hold | $10.7B | 19.06% | 211.02 | -23.81% |
Organization | Bioage Labs Inc. |
Industry | Miscellaneous |
Cactus Acquisition Corp 1 Ltd
$21.93
-2.84%
Rigel Resource Acquisition Corp
$21.93
-2.84%
Everi Holdings Inc
$21.93
-2.84%
Anfield Us Equity Sector Rotation Etf
$21.93
-2.84%
3edge Dynamic Fixed Income Etf
$21.93
-2.84%
Direxion Daily Csi 300 China A Share 2x Shares Etf
$21.93
-2.84%
Dfa Dimensional Us Real Estate Etf
$21.93
-2.84%
Sow Good Inc
$21.93
-2.84%
Uscb Financial Holdings Inc
$21.93
-2.84%